WASHINGTON, Oct. 14, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at Evercore ISI's Catalyst Day on Monday, October 18, 2021. Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board, will take part in a virtual fireside chat at 1:30 PM ET.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
AJ Jones II Chief Corporate Affairs and Communications Officer Vanda Pharmaceuticals Inc. (202) 734-3400 pr@vandapharma.com
Elizabeth Van Every Head of Corporate Affairs Vanda Pharmaceuticals Inc. (202) 734-3400 pr@vandapharma.com
Kevin Moran Senior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc. (202) 734-3400 pr@vandapharma.com
View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-evercore-isis-catalyst-day-301400804.html
SOURCE Vanda Pharmaceuticals Inc.